A thin heart stent for people on blood thinners
Part of Heart & circulation clinical trials.
This trial tests a new type of heart stent in people who also take daily blood thinners. The stent is very thin and releases medicine over time to help keep the artery open, and the coating eventually dissolves. It may be a safer option for people on blood thinners who need a stent.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You take a blood thinner every day (for any reason).
- You need a heart stent for a new blockage (not for a problem with an old stent).
- You have not had a stent placed in the last 6 months that is different from the study stent.
- You are not in shock or recovering from a cardiac arrest at the time of the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how safe and effective a specific stent (SUPRAFLEX CRUZ) is when used in real-world care for people with heart artery blockages in more than one artery. Some participants will also be selected if their heart pumping strength is reduced.
This trial tests a new stent system for treating narrowed heart arteries. If you have coronary artery disease with one or two blockages that are at least 70% narrowed, this procedure might be an option for you.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This study tracks how well a newer heart stent (a small metal tube that keeps arteries open) works in real patients. Researchers want to understand if this specific stent design is safe and effective over time.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.